basic concepts in neonatal ventilation - safe ventilation of neonate
TRANSCRIPT
Muhammad Ezzat Abdel-Shafy
MB.BCh, M.Sc PediatricsNeonatology Sp. , Benha Children Hospital
Physiology of Respiration
INFLUX OF FRESH AIR IN THE LUNG
Inspiration++++
Expiration
++++
Spontaneous Inspiration
Volume Change
Gas Flow
Pressure Difference
Mechanical Ventilation
Pressure Difference
Volume Change
Gas Flow
EQUATION OF MOTION
Force = (E x distance) + (R x speed) + (M x acceleration)
M
E
R
Force
What does the pressure do?
OVERCOMES AIRWAYAND
TISSUE RESISTANCE
.P(resist) = RRS x (V)
where R = resistance
• RRS is the feature of the tube
• Energy lost as heat
What does the pressure do?
OVERCOMES INERTIA
..P(inert) = I x (V)
where I = inertance
• Work done to accelerate
gas and tissue
• Negligible in most instances
What does the pressure do?
INDUCES CHANGE IN
LUNG VOLUME
P(vol) = 1/C x (V)
where C = compliance
Work done to overcome
the viscoelastic forces of
the lung and chest wall
EQUATION OF MOTION APPLIED TO THE LUNG
(single compartment model)
R
Pressure = (1/C x volume) + (R x flow) + (I x acceleration)
P
CRS = V/P
I
Law of LaPlace P = 2 x T/r
T = Surfactant
PEEP PIP
Vo
lum
e Surfactant
The Respiratory Equation of Motion
Pressure = Raw x Flow + CL/Volume
Airways ET tube Lung Chest Wall
C=D V
D P
R =D P
D F
Compliance and Resistance
Airway resistance describes the ability of the conducting part of the lung or the respiratory system to resist air flow
P1 P2
Pressure (P1-P2)
Resistance = P1 P2
Flow
Airway resistance in normal lungs = 25-50 cm H2O/L/sec
In Intubated infants it might be 50-100 cm H2O/L/sec
A B
It is determined by
1- Flow
2- Length of the conductive air way
3- Viscosity of the gases
4- Diameter of the airways
Airway Resistance
R=
8nL/r4
Airway Resistance
P1 P2
Laminar Flow
Turbulent Flow
Compliance describes the elasticity or distensiblility of the respiratory system
(lung and + chest wall)
Compliance
•Tidal volume is only a small
fraction of the total volume of
gas present in the lung during
normal breathing.
•The effect of breathing is to
replenish O2 and to wash out
CO2, but there is not complete
replacement of air in the
lungs or even the alveoli with
each breath.
•RV and FRC cannot be
measured with a spirometer.
•The FRC acts as a buffer
against extreme changes in
the alveolar PO2 and PCO2 with
a single breath.
Pulmonary volumes
and capacities
• Minute respiratory volume (V, minute ventilation)
V = VT * f (respiratory rate)
• Dead space volume (VD)
• Alveolar ventilation (VA): VA = (VT - VD) * f
B. Mechanical Properties of the lung
• Lung Distensibility
• Pressure-volume curve
• Compliance (CL= DV/DP)
• Pulmonary surfactant
surface tension
Laplace Law: P = 2T/r
atelectasis
FUNCTIONS OF SURFACTANT
TLCg = 30 mN/m
FRCg < 5 mN/m
• The distance between alveolar gas and alveolar capillary
lumen is on the order of 1 m
• Even though blood spends less than 1 sec in an alveolar
capillary, CO2 completely equilibrates between alveolar
gas and capillary blood and
• O2 normally equilibrates completely
The Alveolar-
Capillary
Diffusion Path
Length is Very
Short
Ventilator Settings
• Physiological Oxygenation Determinants:
1. Concentration gradient.
2. Surface area of gas exchange.
3. Ventilation perfusion matching
4. Diffusion efficency
Volume
Compliance =
Pressure
Air filed lung: hysteresis
Compliance
Compliance
Mechanical Response to PPVCompliance, CRS
Resistance, RRS
Inspiratory Flow = constant
ΔVL
ΔPLPAO AcDve InspiraDon
Resistance, RRS
Inspiratory Flow
Compliance, CRS
ΔVL
ΔPLPAO = 0 Passive ExpiraDon
Pressure – Flow – Time -Volume• P = (1/CRS) x V + (RRS x Flow)
• VMAX = P x CRS
• Volume change requires time to take place
• When a step change in pressure is applied (P)
volume increases exponentially towards a plateau
Time Constant: (tau) = CRS x RRS
Describes the slope of the exponenDal curve
Volumetric behavior of the lung when exposed to pressure
Salazar & KnowlesJ Appl Physiol 1964
Vmax = maximum lung volume P = applied pressureh = half opening pressure
Time Constant of the Lung
Time Constant: (tau) = CRS x RRS
= Dme required for a 63.2% stepwise change in a measured quanDty (eg volume)
How much of maximum VT
is delivered depends on Ti
How rapidly VT is achieved is determined by and FLOW
Time constants
Time Constant: (tau) = CRS x RRS
Normal lung:
τ 3 mL/cm H2O x 0.04 cm H2O/mL/sec
0.12 sec (insp and exp)
Parenchymal disease:
τ 0.5 mL/cm H2O x 0.04 cm H2O/mL/sec
0.02 sec (insp and exp)
Airway disease:
τ 2 mL/cm H2O x 0.1 cm H2O/mL/sec
0.2 sec (exp > insp)
Effect of varying Time Constants
Understanding Time Constants at
the bedside
• All about the FLOW wave form
Time Constants
What would you do here?
Ti
Te
Zero flow Zero flow Zero flow
Total insp
time
Total insp
time
Total insp
time
Aim for zero flow condition being less than
⅓ of total insp time
How long should you set theTi?
Alveolar Plateau
Leak
Leak
The only true soluDon in the presence of a larger leak is to assess chest wall movement
Expiration is important
Premature flow terminaDon during expiraDon = gas trapping
Auto-PEEP
Functional Residual capacityresidual capacity
Tidal Volume
Inspiratoryreserve volume
Reserve volume
EExpiratoryReserve volume
Vital capacity
Total Lung Capacity
Lung Capacity and Volumes
FRC
FRC
Optimal Lung Inflation
Effect of Lung Volume on PVR
Lung Volume
PVR
Total PVR
Large VesselsSmall Vessels
Atelectasis
Overexpansion
FRC
PVR is the lowest at FRC
Overexpansion of
small vessels PVR
Atelectasis of large
vessels PVR
OxygenaDon
Lung Volume+ Diffusion and perfusion
Goals of mechanical ventilation
Maintain acceptable gas exchange with a minimum of:
lung injury
hemodynamic impairment
other adverse events (i.e. neurologic injury)
Minimize work of breathing
Surfactant deficiency
Alveolar atelectasis
Tidal breathing
High distending
pressure
Stretch and distorsion
Cellular membrane disruption
Protein rich oedema ( hyaline membranes)
Higher [ O2 ] and pressure
Barotrauma PIE, BPD
Need for high [ O2 ]
O2 toxicity
PULMONARY INJURY SEQUENCE
Acute
Lung
inflammation
CNN Rocourt
Ventilator Associated Lung Injury
All forms of positive pressure ventilation (PPV)
can cause ventilator associated lung injury
(VALI).
VALI is the result of a combination of the
following processes:
Barotrauma
Volutrauma
Atelectrauma
Biotrauma
Slutsky, Chest, 1999
Open Lung Ventilation Strategy
Volume
Pressure
Zone of Overdistention
Safe
window
Zone of
Derecruitment
and
atelectasis
Goal is to avoid injury zones
and operate in the safe window
Froese, CCM, 1997
Avoidance of mechanical ventilation
Surfactant replacement
Avoidance of excessive VT (Volume-targeted
ventilation)
Optimization of lung volume/ avoidance of atelectasis
Permissive hypercapnia/ lower SPO2
High-frequency ventilation
(?) Nitric oxide
(?) Liquid ventilation
Lung Injury: Strategies for Prevention
Oxygenation
MAP
PIP
PEEPI/E
ratio
Flow
FIO2
IT ET Time
Base line pressure
MAP
Mean Airway Pressure and How to Increase it
1. Increase PIP
2. Increase PEEP3. Increase IT
4. Increase Flow
4 3
2
Pressure
Cm H2O
I Time E Time I Time
Time (sec)
MAP= K(PIP-PEEP) {IT/(IT+ET)}+PEEP
1
Ventilator Settings
• MEAN AirWay Pressure (Paw)
In retrospect, the simplifying but reductionist elegance that focused upon a single unitary number [P AW ] may have misled the field. (Monkman and Kirpalani 2003).
Ventilator Settings
• Physiological Oxygenation Determinants:
1. Concentration gradient.
2. Surface area of gas exchange.
3. Ventilation perfusion matching
4. Diffusion efficency
Ventilator Settings
• The open lung approach makes the oxygenation improvement by increasing
mean airway pressure a matter of the past.
• The mean airway pressure is to be considered a monitoring tool and a
marker for severity of lung affection (with FiO2 requirements).
CO2 Elimination
MV
FrequencyResistance
Time constant
Tidal Volume
Pressure Gradient Compliance
PEEPPIP
ETI T
I/E ratio
Lung Protective Strategy
Low VT and P makes it possible to use higher PEEP without
high PIP. Ventilation on the expiratory limb of the P-V loop, once
recruitment occurs.
Ventilatory Volumes
VT = 4- 7 ml/kg
VD = 2-2.5 ml/kg
F= 40 -60 breath /minute
MV= 200-480 ml/kg/min
VA= 60-320 ml/kg/min
VT = VD + V A
Minute Ventilation = RR X VT
Minute alveolar ventilation= RR X V A (VT -VD)
Static Lung Volumes
RV= 10-15 ml/kg
FRC= 25-30ml/kg
TLC=50-90 ml/kg
VC= 35-80 ml/kgBaby Lung Concept!!!!
Patient Ventilator Interaction
Patient ventilator interaction can be simplified to three distinct phases:
Patient triggering
Ventilator breath delivery
Ventilator must deliver a sufficient amount of flow to mach or exceed the spontaneously breathing patient’s inspiratory demand
Deliver an adequate tidal volume
An adequate rise to pressure time (in pressure breath only)
The process of cycling the ventilator from inspiration to expiration
Patient-Ventilator AsynchronyPatient ventilator asynchrony will result in
# Impaired gas exchange
#Increased work of breathing
#Increased load to the respiratory muscles
# Increased intrathoracic pressures.
#Increased need for sedation and paralysis.
#Inconsistent tidal volume delivery
#Increased risk of IVH and fluctuations of BP
Neonatal synchrony should aim at preventing ineffective, delayed and double or auto triggering which may impair lung mechanics, gas exchange which in turn can lead to increase use of sedation and prolong the duration of recovery.
Discontinuation from the ventilatory support could be delayed, resulting in more complications.
Variation in tidal volume due to asynchrony in a patient on IMV. b Reduced variation in tidal volume by changing to SIMV Mode. c Improvement in tidal volume by changing to Assist Mode.
Assisted Ventilation of the Newborn 3/e, Goldsmith and Karotkin, Elsevier 2003.
Patient-Ventilator Asynchrony
How to Synchronize:II-Qualitative
Type of trigger
Pressure
Flow
NAVA
Pressure support
The device auto-regulates the PIP (“working pressure”) within preset limit (“pressure limit”) to achieve VT that is set by the user. Regulation of PIP is in response to exhaled VT to minimize artifact due to ETT leak.
Delivery room resuscitation
• The ventilation management efficacy starts in the delivery room.
• It is now well understood that the initial steps in resuscitation
significantly affects the outcome and may determine the pathway
of respiratory care of the patient.
• With good antenatal and delivery room management many
babies will be saved from the topic of this talk.
Adaptation Failure
Delivery room resuscitation
• In full term infants, it is reasonable to initiate resuscitation with air.
Supplementary oxygen may be administered and titrated to achieve a
targeted pre-ductal oxygen saturation.
• In preterm babies <35weeks, it is more sophisticated.
• Several studies comparing low oxygen (21%-30%) with high oxygen (65% or
higher) showed no benefit or harm (PLoS One. 2012;7(12):e52033).
Delivery room resuscitation
• In all studies most of the babies required about 30% at time of stabilization
irrespective to starting point.
• The current recommendation is to use low oxygen (21%-30%) for preterm
infants as a starting point for resuscitation.
• Like the full term babies, titration of oxygen to reach the targeted preductal
oxygen saturation.
• For good use of these recommendation it is of utmost importance to have a
pulse oximeter monitoring during resuscitation.
Delivery room resuscitation
• The resuscitation of preterm babies is more challenging than full term
babies. The smaller the baby, the bigger the challenge.
• The early use of CPAP in delivery room have been showed to be beneficial
and may be superior to more aggressive intubation and ventilation.
• Early CPAP alone without prophylactic surfactant is the preferred option,
with selective surfactant treatment. (SUPPORT trial 2012, European consensus guidelines
for RDS 2013, AAP statement on Respiratory support in preterm infants at birth)
Delivery room resuscitation
• T-Piece resuscitator is the preferred device for resuscitation especially in
preterm babies.
• Sustained Lung Inflation (SLI) is another alternative to fill the lung with
AIR. It showed a decrease in the need for mechanical ventilation in a
historical cohort. Lista G. et al, Neonatology 2011, 99(1):45-50.
• RCTs for SLI are not showing that much difference. SLI STUDY.
Delivery room resuscitation
o Animal studies have suggested that a longer sustained inflation may be beneficial for establishing FRC during transition from fluid-filled to air- filled lungs after birth.
o Human studies showed reduction of the need for MV with sustained inflation. However, no benefit was found for reduction of mortality, bronchopulmonary dysplasia, or air leak.
Pediatrics Jan 2015, peds.2014-1692 (SLI study)
Delivery room resuscitation
PPV and CPAP
• Administration of PPV is the standard recommended treatment for both preterm and term
infants who are apneic. Different devices can be used for PPV.
• The use of PEEP was speculated to be beneficial when PPV is administered to the newly born.
• Few RCTs showed no benefit for PEEP use in preterm infants regarding mortality, need for
cardiac drugs or chest compressions, or resuscitation stabilization at 5 min. However, the use of
PEEP decreased the intubation rate and the maximum pressures applied during PPV. J Pediatr.
2014 Aug;165(2):234-239.e3
• NRP recommends that, when PPV is administered to preterm newborns, use of approximately
5cm H2O PEEP is suggested, which will require the addition of a PEEP valve for self-inflating
bags.
PPV and CPAP
• For many years there have been a debate about early use of CPAP
prophylactically compared to intubation and ventilation for extremely
premature babies.
• Many studies tried to address this issue but there have been no good quality
studies to solve the issue. (Vermond Oxford DRM study).
• And to complicate things more there have been some conflicting data from
some trials. (COIN trial)
PPV and CPAP
• Now there is a good quality evidence that prophylactic CPAP improves many
outcomes compared to intubation and surfactant. It reduces need for MV,
reduces need for surfactant, decreases incidence of BPD and death or BPD,
decrease severe IVH and air leaks. N Engl J Med. 2010 May 27;362(21):1970-9
(SUPPORT study), Cochrane Database of Systematic Reviews 2016, Issue 6. Art. No.:
CD001243
• Based on this evidence, spontaneously breathing preterm infants with
respiratory distress should be supported with CPAP initially rather than
routine intubation for administering PPV.
Physiologic Effects of CPAP
Courtesy of Stewart Hooper
Atmospheric Pressure nCPAP 6 cmH20
Intubation and Surfactant
• The decision to intubate may be a life changer for the baby. The intubation
procedure itself carries many risks and potential complications.
• The intubation is a DE-Stabilizing maneuver.
• Unfortunately, the pre-medication is largely under-used although it is safe,
well tolerated, and decreases the adverse events with intubation plus
increasing chance of successful attempt.
• The most important component is analgesic (mostly opiate). Atropine and
muscle relaxant can be added.
Intubation and Surfactant
INSURESUR LISA
• Less Invasive Surfactant Administration:
• Small feeding tube placed in the trachea under vision using laryngoscope
while the baby is spontaneously breathing on CPAP.
• No baby will be intubated for surfactant administration only.
What about Surfactant
Property Effect
Surface Activity Essential for rapid adsorption and spreading Gravity Surfactant distributed with fluid by gravity in large
airways Volume The higher the volume, the better the distribution Rate of Administration Rapid administration results in a better distribution Ventilator Settings Pressure and positive end-expiratory pressure clear
airways of fluid Fluid Volume in Lung Higher volumes of fetal lung fluid or edema fluid
may result in a better distribution
• Exogenous Surfactant interacts with the type II cells. Surfactant
components are recycled from the airspaces back to type II cells
where lipids are diverted into lamellar bodies for re-secretion.
• Recycling is more efficient in preterm than adult lung, and
recycling rates as high as 80- 90% have been measured in the
newborn. The very long biologic half-life values for airspace
surfactant are explained by continued reuptake and resecretion.
How treatment works
• The treatment dose of surfactant functions as substrate for recycling in the uninjured preterm lung, partially explaining why surfactant treatment effects can persist for days. Surfactant treatment quickly increases the metabolic pool for endogenous metabolism.
• The second bit of magic is the effect that endogenous surfactant metabolism has on the surfactant used for treatment. All surfactants used to treat infants are far from “natural” in that the compositions and lipoprotein aggregate forms differ from the surfactant in the hypo- phase of the healthy lung.
• However, within hours of surfactant treatment, the preterm lamb lung transforms treatment surfactant into a surfactant that is more effective when recovered and used for a second treatment; that is, the surfactant is improved or activated by contact with the preterm lung.
• The presumption is that the lung contributes surfactant proteins and recycles the exogenous surfactant components for secretion in the lung saccules at the right place and time.
• Therefore, the persistence of a surfactant response after a single treatment results from the uninjured lung integrating the exogenous surfactant into endogenous surfactant metabolism, a process that continues over many days. A single treatment can cure the surfactant deficiency disease component of RDS in most infants.
• The crucial variable for the need for a second dose of surfactant is lung injury. The preterm infant who has RDS has a low surfactant pool size, and if lung injury results in edema, the proteins in the edema fluid can inhibit surfactant function. This con- cept can be illustrated by the inverse relationship between oxygenation and minimal surface tension in pre- term lambs following a surfactant treatment
• The crucial variable for the need for a second dose of surfactant is lung injury. The preterm infant who has RDS has a low surfactant pool size, and if lung injury results in edema, the proteins in the edema fluid can inhibit surfactant function.
• The non-responders either have lung injury prior to birth (infection), lung injury after birth and prior to treatment, pulmonary hypoplasia, or a cardio- vascular explanation for the lack of response (low blood pressure, congenital heart disease). The clinician should seek diagnoses other than RDS in the preterm infant who has respiratory failure and does not respond to surfactant.
Matching Ventilatory Setting with Pathophysiologic state
When using ventilation strategy you should pay attention to the
underlying lung condition. There is no one-size-fits-all strategy.
Consider the cause of ventilation, the course of the disease, and
the mechanical derangement.
Notice that with any strategy, the setting adjustment depends
mainly on the lung mechanics.
Normal Lung Ventilation
• Why to ventilate?
• What are mechanical characteristics of
the lungs?
Ventilation Strategy for Normal Lung
Settings
1. Times: 1. Ti: good (0.4-0.5)
2. Rate: med 20-40/min.
2. Pressures:
1. CDP: Low-mod (4-5).
2. Inflating: least to have Vt 4-6
ml/kg (8-10-12).
Attention to cardiovascular interaction with ventilation.
Respiratory Distress Syndrome (RDS)
library.med.utah.edu/WebPath/PEDHTML/PED055.html
Using CPAP immediately after birth with subsequent selective surfactant administration may be considered as an alternative to routine intubation with prophylactic or early surfactant administration in preterm infants. If it is likely that respiratory support with a ventilator will be needed, early administration of surfactant followed by rapid extubation is preferable to prolonged ventilation
Surfactant: How and when
• Prophylactic Surfactant: any place yet??
• Rescue surfactant: early vs. late.
• What type of surfactant to use
animal or synthetic
what animal?
• Technique: no difference
• Stabilization before and after.
• Setting adjustment.
• Surfactant is a powerful recruitment tool
Guidelines for Surfactant Treatment of RDS
< 26 wk 29-31 wk > 32 wk
Early CPAP/NIPPV
Surfactant if intubated
for resuscitation
Early CPAP/NIPPV
Surfactant if intubated
for resuscitation
Observe
CPAP/NIPPV if
respiratory distress
Early Rescue with
100-200 mg/kg if FiO2 >
0.30 + white CXR.
•Start Caffeine
Early Rescue with
100-200 mg/kg if FiO2 >
0.40 + white CXR.
•Start Caffeine
Delayed Rescue with
100 mg/kg if FiO2 > 0.40
+ white CXR
•Caffeine if symptomatic
Redosing:
FiO2 > 0.30
How soon: 2-12 hrs
from the 1st dose
Redosing:
FiO2 > 0.40
How soon: 6-12 hrs
from the 1st dose
Redosing:
FiO2 > 0.40
How soon: 6-12 hrs
from the 1st dose
Ventilation Strategy for RDS
Settings
1. Times:
1. Ti: short (0.2-0.35 sec)
2. Rate: high >60/min.
2. Pressures:
1. CDP: good-high (4-6-8-10!!!!).
2. Inflating: least to have Vt 4-6
ml/kg (12-15).
Pressures need change after
surfactant.
Blood Gases
1. Permissive Hypercapnea
• pCO2 levels 45-65
• pH 7.25-7.3
2. Less Aggressive Oxygenation
Goals
• paO2 45-55
• Saturations 88-92%
Ventilator Settings
• The challenge is to detect the optimal PEEP.
• Failure to give appropriate PEEP will make the heterogeneous pathology of
the lung worse.
“Atelectotrauma”
Expiration
InspirationVentilated
Stable
Ventilated
Unstable Unventilated
Non-Homogenous Aeration in RDS
Recruitment/ de-recruitment injury
Shear forces
Adequate PIP, Insufficient PEEP
CCP COP
CCP = critical closing pressure; COP = critical opening pressure
VT
P
FRC
P
VInspiration
Expiration
Adequate PIP, Adequate PEEP
COP PCCP
FRC
V
VT
P
Good oxygenation, low FiO2, minimal lung injury
CCP = critical closing pressure; COP = critical opening pressure
Ventilator Settings
• The challenge is to detect the optimal PEEP.
• Failure to give appropriate PEEP will make the heterogeneous pathology of
the lung worse.
!
P
COPCCP
!!
VT
FRC
E I
Ventilator Settings
• Trials have been made to adjust PEEP according to P-V loop lower infliction
point. But in newborns with narrow ETT, the resistance of the tube will
distort the shape of P-V loop shifting the lower infliction point.
• It is better practice to titrate PEEP according to lung opening predicton by
oxygenation improvement (good saturation in FiO2<0.25).